Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Earnings Results

Bio Rad Laboratories Misses on EPS, Stock Up 0.5%

Bio Rad Laboratories reported an EPS of $2.33, which was below expectations, resulting in an 18.67% surprise. Despite the earnings miss, the stock reacted positively, increasing by 0.5%. This suggests that investors may be optimistic about the company's long-term strategies and management's focus on innovation, even in the face of short-term challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.33	N/A	-18.67%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism despite missing EPS expectations. They emphasized their commitment to future growth through innovation.

Management acknowledged the challenges faced this quarter but expressed confidence in long-term growth.

They highlighted ongoing investments in innovation as a key focus moving forward.

Bio Rad Laboratories Misses on EPS, Stock Up 0.5%

Key numbers

Management commentary

Bio-Rad Laboratories, Inc.

More earnings this week

Bio Rad Laboratories Misses on EPS, Stock Up 0.5%

Key numbers

Management commentary